Company Filing History:
Years Active: 2017-2023
Title: Innovator Nuria Reig Bolaño: Pioneering Treatments for Amyloidosis
Introduction
Nuria Reig Bolaño is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of biotechnology, particularly in the development of therapies for transthyretin-associated amyloidosis. With a total of 4 patents to her name, her work is paving the way for innovative treatments in this area.
Latest Patents
Nuria's latest patents focus on the use of catechol-O-methyltransferase (COMT) inhibitors for the prevention and treatment of transthyretin-associated amyloidosis. These patents detail the use of COMT inhibitors both as standalone treatments and in combination with other compounds, including benzoxazole derivatives, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, and epigallocatechin-3-gallate. This innovative approach aims to enhance the efficacy of treatments for patients suffering from this condition.
Career Highlights
Nuria Reig Bolaño is currently associated with Som Innovation Biotech, S.L., where she continues to advance her research and development efforts. Her work has garnered attention in the scientific community, contributing to the understanding and treatment of amyloidosis.
Collaborations
Nuria collaborates with notable colleagues, including Marc Centellas Casado and Raúl Insa Boronat. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries.
Conclusion
Nuria Reig Bolaño stands out as a leading inventor in the biotechnology sector, with her innovative patents addressing critical health challenges. Her dedication to advancing treatments for transthyretin-associated amyloidosis exemplifies the impact of her work in the field.